Immune response to third SARS‐CoV‐2 vaccination in seronegative kidney transplant recipients: Possible improvement by mycophenolate mofetil reduction
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune response to third SARS‐CoV‐2 vaccination in seronegative kidney transplant recipients: Possible improvement by mycophenolate mofetil reduction
Authors
Keywords
-
Journal
CLINICAL TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-08-23
DOI
10.1111/ctr.14790
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody Response to a Fourth Messenger RNA COVID-19 Vaccine Dose in Kidney Transplant Recipients: A Case Series
- (2022) Sophie Caillard et al. ANNALS OF INTERNAL MEDICINE
- Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression
- (2022) Daniel R Feikin et al. LANCET
- Effect of Mycophenolate Mofetil Dosing on Antibody Response to SARS-CoV-2 Vaccination in Heart and Lung Transplant Recipients
- (2022) Jonathan Mitchell et al. TRANSPLANTATION
- Enhanced Humoral Immune Response After COVID-19 Vaccination in Elderly Kidney Transplant Recipients on Everolimus Versus Mycophenolate Mofetil–containing Immunosuppressive Regimens
- (2022) Silke E. de Boer et al. TRANSPLANTATION
- Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients
- (2022) Bilgin Osmanodja et al. Journal of Clinical Medicine
- COVID-19 Vaccination Response in Kidney Transplant Recipients With and Without Mycophenolate Mofetil: Follow-up of a Randomized Controlled Trial
- (2022) Zainab Al Fatly et al. Kidney International Reports
- Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study
- (2022) Luuk Wieske et al. Lancet Rheumatology
- Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting
- (2021) Lisa Müller et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
- (2021) Noa Dagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody response to mRNA SARS-CoV-2 vaccine among kidney transplant recipients – Prospective cohort study
- (2021) Benaya Rozen-Zvi et al. CLINICAL MICROBIOLOGY AND INFECTION
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
- (2021) Eric J Haas et al. LANCET
- Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology
- (2021) Stein Bergan et al. THERAPEUTIC DRUG MONITORING
- Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept
- (2021) Nathalie Chavarot et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS‐CoV‐2 vaccination in kidney transplant recipients
- (2021) Marta Kantauskaite et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series
- (2021) William A. Werbel et al. ANNALS OF INTERNAL MEDICINE
- Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses
- (2021) Ilies Benotmane et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults
- (2021) Nawal Al Kaabi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients
- (2021) Dominique Bertrand et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine
- (2021) Ilies Benotmane et al. KIDNEY INTERNATIONAL
- Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination
- (2021) Emma C Wall et al. LANCET
- Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients
- (2021) Dominique Bertrand et al. KIDNEY INTERNATIONAL
- Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection
- (2021) Ital Nemet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination
- (2021) Chris Davis et al. PLoS Pathogens
- Safety and cross-variant immunogenicity of a three-dose COVID-19 mRNA vaccine regimen in kidney transplant recipients
- (2021) Filippo Massa et al. EBioMedicine
- The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study
- (2021) Jeffrey P Townsend et al. Lancet Microbe
- Sepsis in Immunocompromised Patients Without Human Immunodeficiency Virus
- (2020) Randy J McCreery et al. JOURNAL OF INFECTIOUS DISEASES
- Nonlinear Relationship between Mycophenolate Mofetil Dose and Mycophenolic Acid Exposure: Implications for Therapeutic Drug Monitoring
- (2010) B. C. M. de Winter et al. Clinical Journal of the American Society of Nephrology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started